Teodora Djikic

About Teodora Djikic

Teodora Djikic, With an exceptional h-index of 10 and a recent h-index of 9 (since 2020), a distinguished researcher at Univerzitet u Beogradu, specializes in the field of drug design.

His recent articles reflect a diverse array of research interests and contributions to the field:

Virtual Docking, design and in silico ADMET profiling of novel Rho-associated protein kinases-1 (ROCK1) inhibitors

3D-Quantitative Structure-Activity Relationship and design of novel Rho-associated protein kinases-1 (ROCK1) inhibitors

Discovery of new chemotypes of dual 5-HT2A/D2 receptor antagonists with a strategy of drug design methodologies

The evaluation of drug-plasma protein binding interaction on immobilized human serum albumin stationary phase, aided by different computational approaches

Application of computational methods in rational design of multi-target ligands as potential antipsychotics and antidepressants

Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates

Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

A bicyclic α-iminophosphonate improves cognitive decline in 5xFAD murine model of neurodegeneration

Teodora Djikic Information

University

Position

Faculty of Pharmacy

Citations(all)

348

Citations(since 2020)

298

Cited By

137

hIndex(all)

10

hIndex(since 2020)

9

i10Index(all)

10

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Teodora Djikic Skills & Research Interests

drug design

Top articles of Teodora Djikic

Virtual Docking, design and in silico ADMET profiling of novel Rho-associated protein kinases-1 (ROCK1) inhibitors

2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023, BOOK OF PROCEEDINGS

2023

3D-Quantitative Structure-Activity Relationship and design of novel Rho-associated protein kinases-1 (ROCK1) inhibitors

2nd International Conference on Chemo and Bioinformatics, BOOK OF PROOCEEDINGS

2023

Discovery of new chemotypes of dual 5-HT2A/D2 receptor antagonists with a strategy of drug design methodologies

Future Medicinal Chemistry

2022/7

Teodora Djikic
Teodora Djikic

H-Index: 7

Katarina Nikolic
Katarina Nikolic

H-Index: 17

The evaluation of drug-plasma protein binding interaction on immobilized human serum albumin stationary phase, aided by different computational approaches

Journal of Pharmaceutical and Biomedical Analysis

2022/3/20

Application of computational methods in rational design of multi-target ligands as potential antipsychotics and antidepressants

4GPCRnet Symposium

2022

Teodora Djikic
Teodora Djikic

H-Index: 7

Katarina Nikolic
Katarina Nikolic

H-Index: 17

Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates

European Journal of Pharmaceutical Sciences

2022/1/1

Teodora Djikic
Teodora Djikic

H-Index: 7

Katarina Nikolic
Katarina Nikolic

H-Index: 17

Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

European journal of medicinal chemistry

2021/10/15

A bicyclic α-iminophosphonate improves cognitive decline in 5xFAD murine model of neurodegeneration

The FASEB Journal, 2021, vol. 35, num. S1

2021/6/22

A bicyclic α‑iminophosphonate improves cognitive decline in 5xFAD murine model of neurodegeneration

The FASEB Journal

2021/5

An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease

Molecular Informatics

2021/5

In silico identification of novel 5-HT2A antagonists supported with ligand- and target-based drug design methodologies

Journal of Biomolecular Structure and Dynamics

2021/3/8

Seeking SARS-CoV-2 Mpro inhibitors through an integrative in silico approach

18th Hellenic Symposium on Medicinal Chemistry, 25-27 February 2021, Online Symposium

2021

Imidazolines: In silico off-target fishing in the class A of G protein-coupled receptors

Biologia Serbica

2021

Design and Discovery of Kinase Inhibitors Using Docking Studies

2021/1/1

Teodora Djikic
Teodora Djikic

H-Index: 7

Katarina Nikolic
Katarina Nikolic

H-Index: 17

Correction to Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer’s Disease

Journal of Medicinal Chemistry

2020/9/14

Deciphering Imidazoline Off‐targets by Fishing in the Class A of GPCR field

Molecular informatics

2020/7

Bicyclic alfa-iminophosphonates as high affinity imidazoline I2 receptor ligands for Alzheimer's disease

Journal of Medicinal Chemistry, 2020, vol. 63, p. 3610-3633

2020/3/19

Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer’s Disease

Journal of medicinal chemistry

2020/3/9

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs

2020/1/8

Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies

3rd Meeting of the European Research Network on Signal Transduction (ERNEST COST Action CA18133), Signal transduction: From the genomic to the systems level (and everything in between), October 12-14, 2020, Abstract Booklet

2020

See List of Professors in Teodora Djikic University(Univerzitet u Beogradu)

Co-Authors

academic-engine